Emergent Biosolutions reported $1.51B in Equity Capital and Reserves for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 434.85M 9.95M
Akebia Therapeutics AKBA:US $ 62.3M 36.18M
ALKERMES ALKS:US $ 1082.32M 6.93M
Alnylam Pharmaceuticals ALNY:US $ 176.04M 225.13M
Amarin AMRN:US $ 580.04M 61.07M
Ani Pharmaceuticals ANIP:US $ 312.11M 33.99M
Biomarin Pharmaceutical BMRN:US $ 4504.81M 113.49M
Chimerix CMRX:US $ 27.93M 19.87M
Coherus Biosciences CHRS:US $ -22.63M 35.19M
Emergent Biosolutions EBS:US $ 1513.2M 62.1M
Exact Sciences EXAS:US $ 3209.35M 48.86M
Exelixis EXEL:US $ 2293.85M 83.24M
Glaxosmithkline GSK:US $ 16374M 193M
Heron Therapeutics HRTX:US $ 23.96M 53.61M
Immunogen IMGN:US $ 249.83M 56.64M
Intercept Pharmaceuticals ICPT:US $ -369.83M 1.93M
Ironwood Pharmaceuticals IRWD:US $ 532.88M 15.1M
JAZZ PHA JAZZ:US $ 3200.78M 407.71M
Lexicon Pharmaceuticals LXRX:US $ 70.83M 21.87M
Lonza Group LONN:SW 10.01B 261M
Moderna Inc MRNA:US 17.98B 910M
Nektar Therapeutics NKTR:US $ 458.73M 149.16M
Neurocrine Biosciences NBIX:US $ 1423.4M 32.3M
Opko Health OPK:US $ 1718.8M 103.92M
Pacira Pharmaceuticals PCRX:US $ 756.64M 47.06M
Ptc Therapeutics PTCT:US $ -182.22M 91.64M
Sarepta Therapeutics SRPT:US $ 726.46M 130.43M
Seattle Genetics SGEN:US $ 2932.81M 65.66M
Teva Pharmaceutical Industries TEVA:US $ 9037M 307M
United Therapeutics UTHR:US $ 4318.4M 142.1M
Vanda Pharmaceuticals VNDA:US $ 508.55M 6.43M
Xoma XOMA:US $ 134.96M 4.97M